Environmentally Benign Process Icon
Biocatalysis avoids harsh chemicals, metallic catalysts, high energy input , significantly lowering the environmental impact.
2,5-Furandicarboxylic Acid FDCA is a pivotal bio-monomer precursor for next-generation Bio-monomers PEF Plastic Precursor e.g. polyethylene furanoate PEF, a sustainable alternative to PET. The main production challenge is that Chemical conversion of HMF is energy-intensive and requires metallic catalysts , which are costly and difficult to recycle. Furthermore, the furan-based feedstock HMF Hydroxymethylfurfural is unstable , complicating storage and reaction control.
CD Biosynsis offers a clean and efficient biocatalysis solution for FDCA production: Biocatalysis: Whole-cell biotransformation using engineered Pseudomonas or Rhodococcus strains to oxidize HMF to FDCA under mild conditions . This avoids harsh chemicals and high energy input. We maximize the conversion rate through Enzyme Engineering: Directed evolution of Aldehyde Dehydrogenase ADH for high efficiency . Optimizing ADH is key for the oxidation of both aldehyde groups in HMF and its intermediates, ensuring high yield and purity.
Get a QuoteThe industrial production of FDCA faces these key hurdles:
A cost-effective and green solution requires efficient biocatalysts that operate under mild conditions with high specificity.
CD Biosynsis utilizes biocatalysis and enzyme engineering to optimize FDCA production:
Whole-Cell Biocatalysis
We employ engineered Pseudomonas or Rhodococcus strains to co-express the necessary enzymes, performing the HMF oxidation in a single step under mild pH and temperature conditions .
Enzyme Directed Evolution
We use directed evolution or rational design to engineer the rate-limiting Aldehyde Dehydrogenase ADH enzyme to increase its catalytic efficiency and stability for complete oxidation of all aldehyde intermediates.
Co-factor Regeneration Optimization
The oxidation steps require NAD+ as a co-factor. We optimize the host's central metabolism to ensure efficient and continuous regeneration of NAD+ , preventing co-factor limitation and maximizing conversion rate.
High-Purity Product Recovery
FDCA produced biocatalytically has high purity, simplifying downstream processing. We offer optimization of crystallization and acid precipitation protocols for high-yield isolation. [Image of High Conversion Efficiency Icon]
This biocatalytic platform provides an environmentally superior and cost-effective route to high-purity FDCA.
Our FDCA engineering service is dedicated to pursuing the following production goals:
Environmentally Benign Process Icon
Biocatalysis avoids harsh chemicals, metallic catalysts, high energy input , significantly lowering the environmental impact.
High Product Purity and Yield Icon
Enzyme specificity ensures minimal byproduct formation and near-theoretical conversion of HMF to FDCA. [Image of Cost Reduction Icon]
Mild Reaction Conditions Icon
The reaction proceeds efficiently at ambient temperature and pressure , simplifying reactor design and operation.
Efficient HMF Conversion Icon
Whole-cell biocatalysis overcomes HMF instability by rapidly converting the feedstock to the final product FDCA.
Scalable and Robust System Icon
Engineered Pseudomonas/Rhodococcus strains are highly robust and suitable for large-scale biotransformation processes.
We provide a sustainable and cost-competitive platform for PEF plastic precursor production.
Our FDCA biocatalysis engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a green, high-purity FDCA supply. CD Biosynsis provides customized biocatalysis and enzyme engineering solutions:
What is the main environmental advantage of biocatalytic FDCA production ?
Biocatalysis is a greener alternative because it replaces the highly energy-intensive and hazardous chemical oxidation process. It eliminates the need for expensive and toxic metallic catalysts e.g. platinum, and operates under mild conditions ambient temperature and pressure, significantly reducing energy consumption and waste.
Why is Aldehyde Dehydrogenase ADH a key target for enzyme engineering?
The conversion of HMF to FDCA involves the oxidation of both an alcohol and two aldehyde functional groups. The two aldehyde oxidation steps, particularly the final one to the carboxylic acid, are often the rate-limiting steps in the microbial pathway. Directed evolution of ADH is crucial to enhance its specific activity and stability , ensuring rapid and complete conversion to the desired FDCA product.
How does the whole-cell system address HMF instability ?
HMF is chemically unstable and degrades easily. The whole-cell system addresses this by providing a rapid biotransformation rate . The engineered cells quickly uptake the HMF feedstock from the medium and convert it to the stable FDCA product, minimizing the residence time of the unstable intermediate and feedstock in the reactor.
What is the significance of FDCA for the polymer industry ?
FDCA is used to synthesize Polyethylene Furanoate PEF , a bioplastic that offers superior performance e.g. better gas barrier properties than the petroleum-based polyethylene terephthalate PET. As a bio-based monomer, FDCA enables the production of a fully sustainable and high-performance polymer for packaging and beverage bottles.
What is the estimated project timeline?
A comprehensive project involving enzyme engineering, host construction, and process optimization for FDCA biocatalysis typically requires 22-28 weeks for final whole-cell biocatalyst delivery and validated high-titer bioconversion protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.